SLC22A1 and liver disorder: A growing body of evidence suggests that the expression and function of OCT1 changes in liver diseases, which could affect drug disposition in the body, not only by increasing the possibility of DDIs but also by enhancing the complexity of drug treatment (Schaeffeler et al., 2011; Lautem et al., 2013; Li et al., 2019).